Listed by the USPTO as TRAN, ERIC
Tech Center 1600 • Art Units: 1629
This examiner grants 70% of resolved cases
TRAN, ERIC is a USPTO patent examiner in Tech Center 1600 and Art Unit 1629. The record covers 119 resolved cases, a 69.7% allowance rate, and a median of 1028 days to allowance. The 19.4% interview lift provides a meaningful secondary signal and supports considering examiner interviews when a written response alone may not resolve the issues.
Listed companies include Mindset Pharma Inc., Endeavor Biomedicines Inc., and Pfizer Inc. Listed firms include Raphael Bellum PLLC, TROUTMAN PEPPER LOCKE LLP, and BROWN RUDNICK LLP. Practitioners can use the record to prepare application-specific amendments and arguments. The median timeline indicates that prosecution scheduling should account for more than a short examination cycle.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18823254 | 3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses thereof | Non-Final OA | NOVARTIS AG |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Non-Final OA | MINDSET PHARMA INC. |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Non-Final OA | MINDSET PHARMA INC. |
| 18951832 | Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer | Non-Final OA | MIRATI THERAPEUTICS, INC. |
| 17781929 | METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS | Final Rejection | Icahn School of Medicine at Mount Sinai |
| 18416336 | ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS | Non-Final OA | Intervet Inc. |
| 18780727 | METHODS OF TREATING HEART FAILURE WITH HIBERNATING MYOCARDIUM USING MODIFIED FORMS OF TRIMETAZIDINE | Non-Final OA | IMBRIA PHARMACEUTICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy69.7% of resolved applications examined by Eric Tran were allowed (119 resolved cases), compared with 42.4% across Art Unit 1629 over the last five years.
This examiner's interview lift is +19.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Eric Tran took 1,028 days on average from filing to allowance.
Eric Tran examines applications in Art Unit 1629 in Tech Center 1600 (Biotechnology & Pharmaceuticals).